Psychedelic-assisted Group Program for First Responders
Status:
RECRUITING
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
This study is a two-group feasibility study of oral psilocybin combined with a 12-week group-based program, customized for firefighters. Trained facilitators will help create a trauma-informed space for the group (n = 6-8) to thrive and promote cognitive resilience. The topics covered throughout the 12 weeks include breath-work, mindfulness, self-compassion, embodiment, and Internal Family Systems work.
Group 1 (control): 12-week group-based program, with a breathwork day at week 10
Group 2 (intervention): 12-week group-based program, with a 10mg dose of psilocybin (PEX010) at Week 10
Assessment timepoints:
* Baseline
* Mid-program (Week 6)
* End of program (Week 12)
* 6-month follow up
Phase:
PHASE1
Details
Lead Sponsor:
Empower Research Inc
Collaborators:
Centre for Neurology Studies, Canada Empower Psychedelics Mitacs